Submitted:
12 November 2023
Posted:
13 November 2023
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Research overview
Study 1
Methods
Participants and procedure
Data Analyses
Results

Study 2
Methods
Participants and procedure
Measures
Results
Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data availability statement
Conflicts of Interest
References
- World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19. Retrieved on March 11, 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.
- Ministry of Health. Fase 2, Governo vara nuovo Dpcm su riaperture. Retrieved on November 19, 2021. https://www.salute.gov.it/portale/nuovocoronavirus/dettaglioNotizieNuovoCoronavirus.jsp?lingua=italiano&menu=notizie&p=dalministero&id=4772.
- Rogers, R.W. A protection motivation theory of fear appeals and attitude change, Journal of Psychology, 1975, 91, 93–114. [CrossRef]
- Rogers, R.W. Cognitive and physiological processes in fear appeals and attitude change: a revised theory of protection motivation. In J.T. Cacioppo and R.E. Petty (eds) Social Psychophysiology: A Source Book. Guilford Press, New York, 1983, 153–176.
- Betsch, C., Schmid, P., Heinemeier, D., Korn, L., Holtmann, C., & Böhm, R. Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination. PloS one, 2018, 13(12), e0208601. [CrossRef]
- Boss, S. R., Galletta, D. F., Lowry, P. B., Moody, G. D., & Polak, P. What do systems users have to fear? Using fear appeals to engender threats and fear that motivate protective security behaviors. MIS Quarterly, 2015, 39(4), 837–864. [CrossRef]
- Floyd, D. L., Prentice-Dunn, S., & Rogers, R. W. A meta-analysis of research on protection motivation theory. Journal of applied social psychology, 2000, 30(2), 407-429. [CrossRef]
- Ansari-Moghaddam, A., Seraji, M., Sharafi, Z., Mohammadi, M., & Okati-Aliabad, H. The protection motivation theory for predict intention of COVID-19 vaccination in Iran: a structural equation modeling approach. BMC Public Health, 2021, 21(1), 1-9. [CrossRef]
- Li, L., Wang, J., Nicholas, S., Maitland, E., Leng, A., & Liu, R. The Intention to Receive the COVID-19 Vaccine in China: Insights from Protection Motivation Theory. Vaccines, 2021, 9(5), 445. [CrossRef]
- Tong, K. K., He, M., Wu, A., Dang, L., & Chen, J. H. Cognitive Factors Influencing COVID-19 Vaccination Intentions: An Application of the Protection Motivation Theory Using a Probability Community Sample. Vaccines, 2021, 9(10), 1170. [CrossRef]
- Wang, P. W., Ahorsu, D. K., Lin, C. Y., Chen, I. H., Yen, C. F., Kuo, Y. J., ... & Pakpour, A. H. Motivation to have covid-19 vaccination explained using an extended protection motivation theory among university students in china: The role of information sources. Vaccines, 2021, 9(4), 380. [CrossRef]
- Xiao, Q., Liu, X., Wang, R., Mao, Y., Chen, H., Li, X., ... & Zheng, P. (2021). Predictors of Willingness to Receive the COVID-19 Vaccine after Emergency Use Authorization: The Role of Coping Appraisal. Vaccines, 2021, 9(9), 967. [CrossRef]
- Nerini, A., Matera, C., Policardo, G. R., & Di Gesto, C. Containment measures against COVID-19 in Italy: The role of protection motivation and values. Journal of Human Behavior in the Social Environment, 2021, 1-14. [CrossRef]
- Diaz, P., Zizzo, J., Balaji, N. C., Reddy, R., Khodamoradi, K., Ory, J., & Ramasamy, R. Fear about adverse effect on fertility is a major cause of COVID-19 vaccine hesitancy in the United States. Andrologia, 2022, 54(4), e14361. [CrossRef]
- Montagni, I., Ouazzani-Touhami, K., Mebarki, A., Texier, N., Schück, S., Tzourio, C., & Confins Group. Acceptance of a Covid-19 vaccine is associated with ability to detect fake news and health literacy. Journal of public health, 2021, 43(4), 695-702. [CrossRef]
- Muric, G., Wu, Y., & Ferrara, E. COVID-19 vaccine hesitancy on social media: building a public Twitter data set of antivaccine content, vaccine misinformation, and conspiracies. JMIR public health and surveillance, 2021, 7(11), e30642. [CrossRef]
- Duradoni, M., Veloso, M. V., La Gamma, M., Monciatti, A. M., & Guazzini, A. (2022). Italian version of the Vaccination Fear Scale (VFS-6): internal and external validation. Mediterranean Journal of Clinical Psychology, 2022, 10(2).
- Hortal, M., & Di Fabio, J. L. Vaccine rejection and vaccination management: the grey areasRecusa vacinal e gestão da imunização: nuances e contrastes. Revista panamericana de salud publica= Pan American journal of public health, 2019, 43, e54-e54.
- Mellers, B. A., & McGraw, A. P. Anticipated emotions as guides to choice. Current directions in psychological science, 2001, 10(6), 210-214. [CrossRef]
- Sato, R., & Fintan, B. Fear, knowledge, and vaccination behaviors among women in Northern Nigeria. Human Vaccines & Immunotherapeutics, 2020, 16(10), 2438-2448. [CrossRef]
- Tahir, A. I., Ramadhan, D. S., Taha, A. A., Abdullah, R. Y., Karim, S. K., Ahmed, A. K., & Ahmed, S. F. Public fear of COVID-19 vaccines in Iraqi Kurdistan region: a cross-sectional study. Middle East Current Psychiatry, 2021, 28, 1-8. [CrossRef]
- SAGE Working Group. Report of the SAGE working group on vaccine hesitancy. World Health Organization, 2014.
- World Health Organization. Ten Threats to Global Health in 2019. Retrieved on October 3, 2022. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019.
- Howard, M. C. The good, the bad, and the neutral: Vaccine hesitancy mediates the relations of Psychological Capital, the Dark Triad, and the Big Five with vaccination willingness and behaviors. Personality and individual differences, 2022, 190, 111523. [CrossRef]
- Murphy, J., Vallières, F., Bentall, R. P., Shevlin, M., McBride, O., Hartman, T. K., ... & Hyland, P. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nature communications, 2021, 12(1), 29. [CrossRef]
- Weston, R., & Gore Jr, P. A. A brief guide to structural equation modeling. The counseling psychologist, 2006, 34(5), 719-751. [CrossRef]
- Bashirian, S., Jenabi, E., Khazaei, S., Barati, M., Karimi-Shahanjarini, A., Zareian, S., ... & Moeini, B. Factors associated with preventive behaviours of COVID-19 among hospital staff in Iran in 2020: an application of the Protection Motivation Theory. Journal of Hospital Infection, 2020, 105(3), 430-433. [CrossRef]
- Roma, P., Monaro, M., Muzi, L., Colasanti, M., Ricci, E., Biondi, S., ... & Mazza, C. How to improve compliance with protective health measures during the COVID-19 outbreak: testing a moderated mediation model and machine learning algorithms. International journal of environmental research and public health, 2020, 17(19), 7252. [CrossRef]
- Soraci, P., Ferrari, A., Abbiati, F. A., Del Fante, E., De Pace, R., Urso, A., & Griffiths, M. D. Validation and psychometric evaluation of the Italian version of the Fear of COVID-19 Scale. International journal of mental health and addiction, 2020, 1-10. [CrossRef]
- Ahorsu, D. K., Lin, C. Y., Imani, V., Saffari, M., Griffiths, M. D., & Pakpour, A. H. The fear of COVID-19 scale: development and initial validation. International journal of mental health and addiction, 2020, 1-9. [CrossRef]
- Rucker, D. D., Preacher, K. J., Tormala, Z. L., & Petty, R. E. Mediation analysis in social psychology: Current practices and new recommendations. Social and personality psychology compass, 2011, 5(6), 359-371. [CrossRef]
- Hooper, D., Coughlan, J., & Mullen, M.R. Structural equation modelling: Guidelines for determining model fit. Electronic Journal of Business Research Methods, 2008, 6, 53–60.
- Chiorri, C., Bracco, F., Piccinno, T., Modafferi, C., & Battini, V. Psychometric properties of a revised version of the Ten Item Personality Inventory. European Journal of Psychological Assessment, 2015. [CrossRef]
- Gosling, S. D., Rentfrow, P. J., & Swann, W. B. A Very Brief Measure of the Big Five Personality Domains. Journal of Research in Personality, 2003, 37, 504-528. [CrossRef]
- Malas, O., & Tolsá, M. D. Vaccination Fear Scale (VFS-6): Development and Initial Validation. Mediterranean Journal of Clinical Psychology, 2021, 9(2). [CrossRef]
- Everitt, B. S., Landau, S., Leese, M., & Stahl, D. Cluster analysis. John Wiley & Sons, 2011.
- Brumbaugh, J. T., Sokoto, K. C., Wright, C. D., Francis, S. E., Hubbard, J., Alexander, L., & McNeil, D. W. Vaccination intention and uptake within the Black community in Appalachia. Health Psychology, 2023. [CrossRef]
- Simione, L., Vagni, M., Maiorano, T., Giostra, V., & Pajardi, D. How Implicit Attitudes toward Vaccination Affect Vaccine Hesitancy and Behaviour: Developing and Validating the V-IRAP. International Journal of Environmental Research and Public Health, 2022, 19(7), 4205. [CrossRef]
- Lewin, K. Field theory in social science: selected theoretical papers. Ed: Dorwin Cartwright, 1951.
- Deutsch, M., & Gerard, H. B. A study of normative and informational social influences upon individual judgment. The journal of abnormal and social psychology, 1955, 51(3), 629. [CrossRef]
- Kelman, H. C. Compliance, identification, and internalization three processes of attitude change. Journal of conflict resolution, 1958, 2(1), 51-60. [CrossRef]
- Guazzini, A., Fiorenza, M., Panerai, G., & Duradoni, M. What went wrong? Predictors of contact tracing adoption in Italy during COVID-19 pandemic. Future Internet, 2021, 13(11), 286. [CrossRef]
- Matera, C., Paradisi, M., Boin, J., & Nerini, A. Perceived mattering in the face of COVID-19: links with emotion regulation and psychological well-being. Psychology & Health, 2022, 37(12), 1471-1491. [CrossRef]
| Variables | Min-Max | M(SD) |
| TA- Social limitations Severity | 1-5 | 3.94 (1.10) |
| TA- Social limitations Vulnerability | 1-5 | 4.38 (.69) |
| TA-COVID-19 Severity | 1-5 | 4.59 (.72) |
| TA-COVID-19 Vulnerability | 1-5 | 3.14 (1.03) |
| CA-Self-efficacy | 1-5 | 4.33 (.81) |
| CA-Response Efficacy | 1-5 | 4.29 (.87) |
| Fear of COVID-19 | 1-5 | 2.47 (.86) |
| Intention to get vaccinated | 1-5 | 4.54 (.89) |
| Variables | 1. | 2. | 3. | 4. | 5. | 6. | 7. |
| 1.TA-Social limitations Vulnerability | - | ||||||
| 2. TA-Social limitations Severity | .23*** | - | |||||
| 3. TA-COVID-19 Severity | .23*** | .50*** | - | ||||
| 4. TA-COVID-19 Vulnerability | .23*** | .33*** | .32*** | - | |||
| 5. CA-Self-efficacy | .29*** | .42*** | .42*** | .29*** | - | ||
| 6. CA-Response Efficacy | .36*** | .60*** | .57*** | .37*** | .62*** | - | |
| 7. Fear of COVID-19 | .22*** | .27*** | .20** | .59*** | .19** | .35*** | - |
| 8. Intention to get vaccinated | .24*** | .47*** | .47*** | .21** | .66*** | .71*** | .26*** |
| Variables | Entire Sample | Females | Males |
| M (SD) | M (SD) | M (SD) | |
| Age | 38.33 (13.94) | 38.05 (13.82) | 38.67 (14.44) |
| Extraversion | 8.19 (2.76) | 8.38 (2.85) | 7.74 (2.50) |
| Agreeableness | 10.38 (2.03) | 10.49 (2.01) | 10.05 (2.08) |
| Conscientiousness | 10.42 (2.36) | 10.57 (2.28) | 10.12 (2.44) |
| Neuroticism | 7.62 (2.77) | 7.90 (2.73) | 6.94 (2.74) |
| Openness | 9.07 (2.12) | 9.09 (2.09) | 4.37 (2.31) |
| VF Cognitive | 7.61 (4.07) | 7.74 (4.19) | 6.94 (3.66) |
| VF Somatic | 5.00 (3.01) | 5.18 (3.19) | 4.37 (2.31) |
| VH Confidence | 10.21 (1.35) | 10.18 (3.30) | 10.53 (3.46) |
| VH Complacency | 5.44 (2.83) | 5.17 (2.60) | 5.94 (3.20) |
| VH Constraints | 4.77 (2.29) | 4.66 (2.20) | 4.82 (2.35) |
| VH Calculation | 11.03 (2.65) | 11.00 (2.53) | 11.00 (2.91) |
| VH Collective responsibility | 11.95 (3.00) | 12.15 (2.84) | 11.66 (3.26) |
| Predictors | Coefficient |
| VH Confidence | 0.31 |
| VH Complacency | -0.23 |
| VH Constraints | ns |
| VH Calculation | -0.12 |
| VH Collective responsibility | 0.57 |
| Predictors | VH Confidence | VH Complacency | VH Calculation | VH Collective responsibility |
| Age | -0.04 | -0.01 | 0.07* | -0.06* |
| Sex | 0.01 | -0.16*** | -0.04 | 0.12*** |
| Extraversion | 0.02 | 0.01 | 0.02 | -0.01 |
| Agreeableness | 0.01 | -0.06* | 0.07* | 0.02 |
| Conscientiousness | 0.02 | -0.02 | 0.04 | 0.01 |
| Neuroticism | 0.06** | -0.16** | -0.02 | 012*** |
| Openness | -0.02 | 0.05* | 0.01 | -0.02 |
| VF Cognitive | -0.76*** | 0.57*** | 0.38*** | -0.60*** |
| VF Somatic | -0.02 | 0.11*** | 0.01 | -0.11*** |
| R2 | 0.60 | 0.46 | 0.17 | 0.49 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).